Anlon Healthcare Ltd vs Chemcrux Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 121.35 as of 20 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Chemcrux Enterprises Ltd changed from 15.3 on March 2022 to 38.1 on March 2025 . This represents a CAGR of 25.62% over 4 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Chemcrux Enterprises Ltd changed from ₹ 226.58 crore on March 2022 to ₹ 148.9 crore on March 2025 . This represents a CAGR of -9.96% over 4 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Chemcrux Enterprises Ltd for the Dec '25 is ₹ 22.72 crore as compare to the Sep '25 revenue of ₹ 18.37 crore. This represent the growth of 23.68% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Chemcrux Enterprises Ltd for the Dec '25 is ₹ 4.13 crore as compare to the Sep '25 ebitda of ₹ 2.42 crore. This represent the growth of 70.66% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Chemcrux Enterprises Ltd changed from ₹ 1.24 crore to ₹ 1.58 crore over 7 quarters. This represents a CAGR of 14.85% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Chemcrux Enterprises Ltd changed from 11.06 % on March 2021 to 35.35 % on March 2025 . This represents a CAGR of 26.16% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Chemcrux Enterprises Ltd

Chemcrux Enterprises Limited was incorporated on April 15, 1996 with Registrar of Companies, Gujarat Dadra and Nagar Haveli.
The Company took over the business of M/s.
Chemcrux, a Partnership Firm in December, 1999, which was formed in 1981. Chemcrux Enterprises Limited is an ISO 9001:2008 and ISO 14001:2004 certified company and is engaged in High Pressure Oxidation, Chlorosulfonation, Nitration and Amidation Chemistry for manufacturing of intermediates for bulk drugs i.e.
APIs, dyes and pigments.
The Companys major selling products are Lassamide, various Chloro Benzoic Acids, and Nitro Benzoic Acids.

FAQs for the comparison of Anlon Healthcare Ltd and Chemcrux Enterprises Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Chemcrux Enterprises Ltd?

Market cap of Anlon Healthcare Ltd is 644 Cr while Market cap of Chemcrux Enterprises Ltd is 116 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Chemcrux Enterprises Ltd?

The stock performance of Anlon Healthcare Ltd and Chemcrux Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Chemcrux Enterprises Ltd?

As of March 22, 2026, the Anlon Healthcare Ltd stock price is INR ₹121.35. On the other hand, Chemcrux Enterprises Ltd stock price is INR ₹78.96.

How do dividend payouts of Anlon Healthcare Ltd and Chemcrux Enterprises Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Chemcrux Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.